21 May 2013
Keywords: neurosearch, obesity, drug, fares, well, ph, ii
Article | 10 November 2008
Danish drug developer Neurosearch says that its drug candidate tesofensine can produce twice the weight loss of currently-approved
obesity treatments, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 November 2008
20 May 2013
© 2013 thepharmaletter.com